Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
MARKET INSIGHTS
The global 1.5T helium-free MRI system market size was valued at USD 959 million in 2024. The market is projected to grow from USD 1,010 million in 2025 to USD 1,385 million by 2031, exhibiting a CAGR of 5.2% during the forecast period.
A 1.5T Helium-Free Magnetic Resonance Imaging (MRI) System is an advanced diagnostic device that operates at the standard clinical field strength of 1.5 Tesla but eliminates the dependency on liquid helium. Traditional MRI systems require large quantities of liquid helium to cool their superconducting magnets to extremely low temperatures; however, this new generation utilizes innovative cooling technologies, such as conduction cooling with cryocoolers, and advanced superconducting materials. This fundamental design shift mitigates the operational risks and significant costs associated with helium supply volatility and potential quench events.
The market growth is primarily driven by the compelling operational advantages of helium-free systems, including significantly lower lifetime costs due to the removal of helium replenishment expenses, simplified site planning, and enhanced operational stability. Furthermore, growing global concerns regarding helium scarcity and supply chain resilience are prompting healthcare providers to invest in future-proof technology. Key industry players like Siemens Healthineers AG and Koninklijke Philips NV are actively advancing this segment with new product launches, consolidating their market positions and accelerating adoption across hospitals and research institutes globally.
Growing Demand for Cost-Effective and Sustainable Medical Imaging
The shift towards helium-free MRI systems is primarily propelled by the need to reduce operational costs and enhance sustainability in healthcare. Traditional 1.5T MRI scanners require significant amounts of liquid helium for cooling superconducting magnets, which is expensive and subject to supply chain volatility. Helium-free systems, utilizing cryocooler technology, eliminate these recurring costs and the logistical challenges of helium procurement. This is particularly attractive for imaging centers and hospitals operating in budget-constrained environments, as it lowers the total cost of ownership substantially.
Advancements in Cryogen-Free Magnet Technology
Significant technological innovations have made 1.5T helium-free systems a viable and reliable alternative. Modern systems employ advanced cryocoolers that maintain the required superconducting temperatures without liquid helium. These technological improvements ensure that image quality and system performance are on par with traditional helium-cooled systems, meeting the clinical standards required for accurate diagnosis. This reliability is a key factor driving adoption among healthcare providers.
➤ The stability and image quality of newer 1.5T helium-free models have been validated in clinical settings, demonstrating diagnostic capabilities equivalent to conventional systems.
Furthermore, the expansion of healthcare infrastructure in emerging markets is creating new demand for advanced imaging technologies. Helium-free MRI systems are easier to install and maintain in regions with less developed support infrastructure, making them an ideal solution for expanding access to high-quality diagnostic imaging globally.
MARKET CHALLENGES
High Initial Capital Investment
Despite long-term operational savings, the upfront cost of acquiring a 1.5T helium-free MRI system can be a significant barrier. These systems often carry a higher purchase price compared to some traditional models, which can deter budget-conscious facilities from making the initial investment. Securing financing for this capital expenditure remains a challenge for many smaller clinics and hospitals.
Other Challenges
Market Penetration and Physician Familiarity
There is a natural inertia in the medical community towards adopting new technology. Many radiologists and technicians are highly familiar and comfortable with traditional helium-cooled 1.5T systems. Gaining clinical acceptance requires extensive training, demonstration of equivalent performance, and time for the market to build confidence in the new technology's reliability.
Technical Service and Support Infrastructure
The specialized nature of cryogen-free technology necessitates a new ecosystem of trained service engineers. The current service infrastructure is predominantly built around traditional MRI systems, and building a comparable support network for helium-free models is an ongoing challenge that manufacturers must address to ensure widespread adoption.
Competition from Refurbished Traditional MRI Systems
A major factor restraining the growth of the 1.5T helium-free MRI market is the strong competition from the robust market for refurbished traditional MRI systems. These pre-owned systems offer a much lower initial purchase price, making them an attractive option for cost-sensitive buyers, even though they inherit the ongoing helium-related operating expenses. This price competition can slow the replacement cycle and delay investment in newer helium-free technology.
Perceived Performance Limitations for High-End Applications
While 1.5T helium-free systems are excellent for routine clinical imaging, there is a perception among some specialists that for certain advanced neurological or musculoskeletal applications, higher-field systems (3T and above) or established traditional 1.5T systems may offer marginal advantages. This perception can limit the adoption of helium-free 1.5T systems in academic medical centers and facilities specializing in complex cases.
Expansion into Outpatient and Ambulatory Care Centers
The trend towards decentralized healthcare presents a significant opportunity for 1.5T helium-free MRI systems. Their compact design, simplified installation (no need for quench pipes), and lower operational overhead make them perfectly suited for outpatient imaging centers, ambulatory surgical centers, and specialized clinics. This facilitates bringing advanced diagnostic capabilities closer to patients, improving access and convenience.
Strategic Focus on Sustainability and Green Hospitals
The growing emphasis on environmental sustainability in healthcare is a powerful driver. Hospitals are increasingly seeking "green" technologies to reduce their carbon footprint and operational waste. Helium-free MRI systems align perfectly with this initiative by eliminating helium consumption and the associated environmental impact of its extraction and transportation. Marketing this sustainability advantage can be a key differentiator.
Technological Integration and Workflow Efficiency
There is an opportunity to integrate helium-free 1.5T systems with advanced software platforms for artificial intelligence (AI) and workflow optimization. The inherent operational stability of these systems makes them ideal platforms for deploying AI-driven applications for image reconstruction, protocol optimization, and automated reporting, thereby increasing throughput and diagnostic efficiency for healthcare providers.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
16 Channels systems are the leading segment, primarily due to their superior imaging capabilities and faster scan times that significantly enhance diagnostic throughput for busy clinical environments. These high-channel systems offer exceptional signal-to-noise ratios, which are crucial for producing the high-resolution images needed for complex diagnostic procedures. The preference for 16-channel systems is reinforced by technological advancements that maximize the benefits of helium-free designs, making them highly desirable for facilities aiming for top-tier clinical performance. This segment's growth is driven by the increasing demand for accurate and efficient diagnostic imaging, positioning it firmly as the preferred choice among medical professionals seeking to optimize their diagnostic workflows without the operational burdens of traditional helium-cooled systems. |
| By Application |
|
Hospital applications represent the dominant segment, leveraging the operational efficiencies and cost-effectiveness of helium-free technology for high-volume diagnostic imaging. Hospitals benefit immensely from the simplified installation process and reduced maintenance requirements, which minimize operational disruptions and lower the total cost of ownership. The reliability of these systems supports critical clinical decision-making across various departments, including neurology, cardiology, and oncology. The growing adoption in hospital settings is further propelled by the need for scalable and sustainable imaging solutions that can adapt to increasing patient loads. This makes the hospital segment a cornerstone of market demand, as institutions prioritize technologies that enhance diagnostic accuracy while streamlining operational logistics and reducing dependency on complex helium supply chains. |
| By End User |
|
Large Hospital Networks are the leading end-user segment, driven by their strategic initiatives to standardize advanced, cost-effective imaging technologies across multiple facilities. These networks value the helium-free system's ability to deliver consistent, high-quality diagnostic performance without the logistical challenges associated with helium replenishment. The scalability of these systems allows for seamless integration into existing infrastructure, supporting centralized purchasing and maintenance strategies that yield significant operational savings. Furthermore, large networks are often early adopters of innovative technologies that promise enhanced patient care and operational resilience, making them pivotal in driving market penetration. Their influence is amplified by the trend towards value-based care, where reliable and efficient diagnostic tools are essential for improving patient outcomes and optimizing resource allocation across expansive healthcare systems. |
| By Technology Adoption |
|
Early Adopters constitute the leading segment, characterized by pioneering healthcare institutions and research centers that prioritize technological innovation to gain a competitive edge. These users are typically motivated by the significant long-term benefits of helium-free systems, including elimination of helium supply risks, reduced operational costs, and enhanced system uptime. Their successful deployment and positive operational experiences serve as influential case studies that accelerate broader market acceptance. Early adopters often collaborate closely with manufacturers to refine system capabilities, fostering continuous innovation and reliability improvements. This segment's proactive approach is crucial for validating the clinical and economic advantages of helium-free technology, thereby paving the way for its integration into standard medical imaging protocols and encouraging more conservative institutions to follow suit as the technology matures and demonstrates sustained performance. |
| By System Configuration |
|
Fixed Systems are the dominant configuration, preferred for their stable installation in dedicated imaging suites within hospitals and large diagnostic centers. The inherent reliability and robust performance of fixed helium-free MRI systems make them ideal for high-throughput clinical environments where consistent image quality is paramount. These systems benefit from permanent infrastructure support, which optimizes their operational efficiency and integration with other hospital information systems. The elimination of liquid helium concerns is particularly advantageous for fixed installations, as it enhances safety and reduces the need for specialized facility modifications. The leading position of fixed systems is reinforced by their ability to meet the demanding requirements of routine and specialized diagnostic imaging, providing a dependable solution that aligns with the long-term strategic investments of healthcare providers seeking to future-proof their imaging capabilities. |
An Evolving Market with Strong Growth Potential
The global 1.5T Helium-Free MRI System market is characterized by the dominance of a few major multinational corporations, primarily Koninklijke Philips NV and Siemens Healthineers AG. These established medical imaging giants leverage their extensive research and development capabilities, global sales networks, and strong brand recognition to maintain significant market share. In 2024, the global top five players collectively held a substantial portion of the market revenue. The competitive dynamics are shaped by continuous technological innovation aimed at improving image quality, reducing operational costs, and enhancing user-friendliness. The industry is also subject to varying international trade policies, including U.S. tariffs, which influence supply chain strategies and regional market competitiveness.
Alongside the global leaders, the market includes a cohort of specialized and regional players that compete by offering cost-effective solutions and targeting specific niches. Companies such as SternMed GmbH. and Hallmarq Veterinary Imaging focus on particular applications, with the latter carving out a strong position in the veterinary medicine segment. A significant number of manufacturers based in Asia, including FMI Medical Systems Co., Ltd., Shenzhen Basda Medical Apparatus Co., Ltd, and Beijing Wandong Medical Technology Co.,Ltd., are increasingly influential, driving competition through competitive pricing and catering to the growing demand in emerging markets. These companies are expanding their presence by addressing the need for accessible and lower-maintenance MRI systems in hospitals and research institutes globally.
List of Key 1.5T Helium-Free MRI System Companies ProfiledKoninklijke Philips NV
Hallmarq Veterinary Imaging
Imotek International
Shenzhen Basda Medical Apparatus Co., Ltd
Beijing Wandong Medical Technology Co.,Ltd.
Xingaoyi Medical Equipment Co.,Ltd
AllTech Medical Systems
United Imaging Healthcare
Time Medical Systems
The global 1.5T Helium-Free MRI System market is on a strong growth trajectory, valued at $959 million in 2024 and projected to reach $1,385 million by 2031, representing a compound annual growth rate (CAGR) of 5.2%. This growth is primarily fueled by the significant operational and economic advantages of helium-free technology over traditional MRI systems. By eliminating the dependency on liquid helium for cooling superconducting magnets, these systems remove the risks and high costs associated with helium supply, replenishment, and potential quenching events. This innovation provides medical institutions with a safer, more cost-effective imaging solution that is easier to install and maintain, with less stringent site requirements.
Other TrendsMarket Segmentation Dynamics
The market is segmented by type, with 16-channel systems representing a key growth area. Different channel configurations cater to varying clinical needs, balancing imaging speed, resolution, and cost. The application segment is dominated by hospitals, which are the primary purchasers, followed by research institutes that utilize these systems for advanced medical studies. Geographically, North America, particularly the United States, is a major market, while the Asia-Pacific region, led by China, is anticipated to exhibit significant growth potential due to expanding healthcare infrastructure and increasing adoption of advanced medical technologies.
Competitive Landscape and Strategic FocusThe global competitive landscape features key players such as Koninklijke Philips NV and Siemens Healthineers AG, alongside specialized manufacturers like SternMed GmbH and Hallmarq Veterinary Imaging. The market is characterized by technological innovation focused on improving image quality, workflow efficiency, and operational reliability. Companies are actively engaged in research and development to enhance their product portfolios and expand their global footprint. A major strategic focus for manufacturers is navigating international trade policies and supply chain dynamics to ensure market resilience and competitive positioning, which can significantly influence regional market structures and economic performance.
Regional Analysis: 1.5T Helium-Free MRI System MarketEurope
Europe represents a highly significant and rapidly growing market for 1.5T helium-free MRI systems, characterized by a strong alignment with the region's stringent environmental regulations and sustainability goals. Countries like Germany, France, and the United Kingdom are at the forefront of adoption, driven by both public and private healthcare sectors seeking to modernize their imaging fleets. The European regulatory environment, with its focus on green technologies and energy efficiency, provides a tailwind for helium-free systems, which are perceived as a more environmentally responsible choice compared to traditional MRI units. There is a notable trend of hospital groups making strategic, long-term decisions to phase out helium-dependent systems in favor of more resilient and operationally simpler technologies. Market growth is also supported by the presence of major research institutions that value the technological advantages and reliability offered by these systems for both clinical and research applications.
Asia-Pacific
The Asia-Pacific region exhibits the most dynamic growth potential for the 1.5T helium-free MRI system market, fueled by massive healthcare infrastructure expansion, rising medical tourism, and increasing healthcare expenditure. Markets such as China, Japan, South Korea, and India are key drivers, with many new hospitals and imaging centers being built with a focus on adopting the latest available technology from the outset. This allows for a "leapfrog" effect, where these new facilities can bypass the challenges of helium management entirely. Governments in the region are actively investing in upgrading public healthcare infrastructure, creating significant opportunities. However, market penetration varies widely, with price sensitivity remaining a key consideration in many countries, potentially slowing adoption rates compared to more affluent regions despite the clear long-term operational benefits.
South America
The South American market for 1.5T helium-free MRI systems is in a nascent but promising stage of development. The primary adoption is currently concentrated in major urban centers within countries like Brazil and Argentina, where leading private hospital networks are beginning to invest in this technology to differentiate their services and attract patients seeking high-quality, reliable diagnostic care. The value proposition of reduced long-term operational costs and independence from volatile helium supply chains is particularly appealing in a region where economic stability can be a concern. However, market growth is tempered by budgetary constraints within public health systems and a generally slower rate of technological refresh compared to North America or Europe. Overcoming initial capital cost barriers remains the key challenge for wider market expansion across the continent.
Middle East & AfricaMiddle East & Africa
Adoption of 1.5T helium-free MRI systems in the Middle East and Africa is highly selective and primarily driven by affluent Gulf Cooperation Council (GCC) countries, such as the United Arab Emirates and Saudi Arabia. These nations are building world-class healthcare cities and medical tourism hubs that prioritize the latest medical technologies, including helium-free MRIs, as a marker of excellence and innovation. The technology's resilience to environmental extremes and logistical simplicity is a significant advantage in these geographies. In contrast, across much of Africa, market development is extremely limited, hindered by fundamental infrastructure challenges, severe budget limitations, and a focus on acquiring more basic diagnostic equipment. The regional market is therefore a tale of two extremes, with high-end adoption in specific wealthy enclaves and very minimal penetration elsewhere.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2031. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Research institutions
Investors and consulting firms
Policy makers and regulatory bodies
-> Global 1.5T Helium-Free MRI System market was valued at USD 959 million in 2024 and is expected to reach USD 1,385 million by 2031.
Which key companies operate in Global 1.5T Helium-Free MRI System Market?
-> Key players include Koninklijke Philips NV, Siemens Healthineers AG, SternMed GmbH, and Hallmarq Veterinary Imaging, among others.
-> Key growth drivers include helium scarcity concerns, lower operational costs, and advanced diagnostic needs.
-> North America leads the market, while Asia-Pacific shows highest growth potential.
-> Emerging trends include conduction cooling systems, compact designs, and veterinary applications.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates